---
title: "Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer: Access and coverage questions"
description: "Access and coverage questions on Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing, Access and support, Cost and coverage, and Prior authorization. Questions: What is the NDC for TRODELVY? Does TRODELVY have copay or patient assistance programs? What is the J-code for TRODELVY? How much does TRODELVY cost with the Gilead Oncology Co-pay Program? 3 further questions follow. 7 questions quoted from 3 sources."
canonical: "https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/access-and-coverage"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer: Access and coverage questions

Manufacturer: Gilead Sciences, Inc.  
Prescribing information: [Trodelvy](https://www.gilead.com/-/media/files/pdfs/medicines/oncology/trodelvy/trodelvy_pi.pdf)

## Access and billing

<a id="trodelvy-ndc"></a>

### What is the NDC for TRODELVY?

> “TRODELVY for injection is a sterile, off-white to yellowish lyophilized powder in a single-dose vial. Each TRODELVY vial is individually boxed in a carton:
>
> NDC 55135-132-01 contains one 180-mg vial”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-08](https://www.trodelvyhcp.com/reconstitution-and-administration#:~:text=TRODELVY%20for%20injection%20is%20a,55135%2D132%2D01%20contains%20one%20180%2Dmg%20vial)

## Access and support

<a id="trodelvy-financial-support"></a>

### Does TRODELVY have copay or patient assistance programs?

> “If your patient is commercially or privately insured, the Gilead Oncology Co-pay Program<sup>a</sup> offers savings on out-of-pocket expenses of TRODELVY 180-mg single-dose vials, up to $25,000 annually. Terms and conditions apply.”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=If%20your%20patient%20is%20commercially,annually.%20Terms%20and%20conditions%20apply.)

> “<sup>b</sup>Patients with Medicare or other government insurance who need assistance with cost-share requirements for TRODELVY may be eligible for assistance through an independent co-pay assistance foundation.”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=with%20Medicare%20or%20other%20government,an%20independent%20co%2Dpay%20assistance%20foundation.)

On the page, select: Government

> “Patient Support Offerings (includes: Benefits Investigation, Prior Authorization and Appeals Information, and Patient Assistance Program [PAP] Eligibility Screening, if applicable)
> Gilead Oncology Co-Pay Program Eligibility Screening”

Source: [TRODELVY: Patient Access Support Enrollment Form Download, page 1, captured 2026-11-08](https://www.trodelvyhcp.com/-/media/affinity/trodelvyhcp/resourcefilter/trodelvy-patient-access-support-enrollment-form-aug-2022.pdf#page=1)

Note: The first passage is from the Commercial or Private tab of the Financial Assistance page and the second from its Government tab; the third is the support-request section of the Gilead Oncology Support enrollment form that the resources library links. The page's No Insurance tab was not captured, so assistance for uninsured patients is not quoted.

<a id="trodelvy-j-code"></a>

### What is the J-code for TRODELVY?

> “J-Code J9317: Injection, sacituzumab govitecan-hziy, 2.5 mg”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-08](https://www.trodelvyhcp.com/reconstitution-and-administration#:~:text=J%2DCode%20J9317%3A%20Injection%2C%20sacituzumab%20govitecan%2Dhziy%2C%202.5%20mg)

<a id="trodelvy-reimbursement-support"></a>

### How do you contact TRODELVY reimbursement support?

> “Gilead Oncology Support provides dedicated support to patients, helping them understand coverage and financial options for their prescribed TRODELVY. For full program details, visit www.gileadoncologysupport.com.”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=Gilead%20Oncology%20Support%20provides%20dedicated,full%20program%20details%2C%20visit%20www.gileadoncologysupport.com.)

> “Live support is available for eligible individuals
>
> Program specialists are available to provide information and answer questions.
>
> Call 844-876-3358 Mon–Fri 9 AM to 7 PM ET
>
> To request an appointment with a field reimbursement manager, visit www.gileadoncologysupport.com.”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=Live%20support%20is%20available%20for,field%20reimbursement%20manager%2C%20visit%20www.gileadoncologysupport.com.)

## Cost and coverage

<a id="trodelvy-copay-program-cost"></a>

### How much does TRODELVY cost with the Gilead Oncology Co-pay Program?

> “If your patient is commercially or privately insured, the Gilead Oncology Co-pay Program<sup>a</sup> offers savings on out-of-pocket expenses of TRODELVY 180-mg single-dose vials, up to $25,000 annually. Terms and conditions apply.
> Patients may pay as little as $0 out of pocket for TRODELVY, which includes co-pay and coinsurance, up to $25,000 annually
> The program only assists with the cost of TRODELVY; patient is responsible for cost-share of treatments and office visits”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=If%20your%20patient%20is%20commercially,of%20treatments%20and%20office%20visits)

> “<sup>a</sup>Co-pay support is available for commercially insured, eligible individuals only. Additional restrictions may apply. Subject to change. For full terms and conditions, visit www.gileadoncologysupport.com. This is not health insurance.”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=support%20is%20available%20for%20commercially,This%20is%20not%20health%20insurance.)

<a id="trodelvy-medicare-copay-help"></a>

### Can Medicare patients get help paying for TRODELVY?

> “This program does not support any claims covered, paid, or reimbursed in whole or in part by Medicaid, Medicare, or other federal or state healthcare programs”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=This%20program%20does%20not%20support,federal%20or%20state%20healthcare%20programs)

> “This option may be available if your patient is enrolled in government healthcare programs, such as Medicare, Medicaid, TRICARE, or VA, or is otherwise not eligible for Gilead’s co-pay program.<sup>b</sup>”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=This%20option%20may%20be%20available,not%20eligible%20for%20Gilead%E2%80%99s%20co%2Dpay)

On the page, select: Government

> “<sup>b</sup>Patients with Medicare or other government insurance who need assistance with cost-share requirements for TRODELVY may be eligible for assistance through an independent co-pay assistance foundation. Program specialists can help patients assess their high-level eligibility for possible coverage for TRODELVY through an independent co-pay assistance foundation. If co-pay assistance needs are identified, the program specialists can provide information about any available foundations. The foundation will determine the patient’s eligibility for assistance based on their own criteria, completely independent of Gilead and its agents, and will contact the patient directly regarding the application process. Gilead and its agents make no guarantee regarding reimbursement for any service or item.”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=with%20Medicare%20or%20other%20government,for%20any%20service%20or%20item.)

On the page, select: Government

Note: The first passage describes the Gilead Oncology Co-pay Program for commercially insured patients; the others appear under the Government tab of the same page.

## Prior authorization

<a id="trodelvy-prior-authorization-support"></a>

### Is TRODELVY prior authorization and appeals information available?

> “Gilead Oncology Support is here to guide your patients through every step of the treatment journey, from understanding insurance coverage to exploring financial assistance options.
>
> Coverage Support
>
> Benefits Investigation
>
> Prior Authorization & Appeals Process Information”

Source: [TRODELVY: TRODELVY (sacituzumab govitecan-hziy) - For Healthcare Professionals, captured 2026-11-13](https://www.trodelvyhcp.com/financial-assistance#:~:text=Gilead%20Oncology%20Support%20is%20here,Authorization%20%26%20Appeals%20Process%20Information)

## Related pages
- [Medical information: Trodelvy (sacituzumab govitecan-hziy): Metastatic triple-negative breast cancer](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer)
- [Indication](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/safety)
- [Specific populations](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/dosing-and-administration)
- [Guidelines](https://www.evicenter.com/medical-information/trodelvy--metastatic-triple-negative-breast-cancer/guidelines)
